|
|
File #:
|
220203
Version:
1
|
Name:
|
Accept and Expend Grant - Retroactive - National Institutes of Health - Heluna Health - Mirtazapine for Methamphetamine Use Disorder: Drug-drug Interaction Study - $112,056
|
|
Type:
|
Resolution
|
Status:
|
Filed
|
|
On agenda:
|
|
Final action:
|
9/27/2022
|
|
Enactment date:
|
|
Enactment #:
|
|
|
Title:
|
Resolution retroactively authorizing the Department of Public Health to accept and expend a grant increase in the amount of $56,124 from the National Institutes of Health through Heluna Health for a total amount of $112,056 for participation in a program, entitled “Mirtazapine for Methamphetamine Use Disorder: Drug-drug Interaction Study,” for the period of June 1, 2021, through May 31, 2022.
|
|